Scottsdale Adolescent Gynecomastia
Adolescent gynecomastia has been diagnosed in 50% of adolescent males. While most glandular growth occurs in males between the ages of 10 to 13, an imbalance between estrogen and testosterone is one of the primary reasons for youth gynecomastia cases. In many cases, maturity eliminates adolescent gynecomastia; however, for 30% of males, the tissue never diminishes. Surgery, in most cases, is the only treatment option.
Currently, there are no drugs approved by the FDA for the treatment of gynecomastia. Drugs such as danazol and tamoxifen interrupt estrogen production, but have yet to be authorized by the FDA